[{"Assets_0_Q1_USD":6543114000.0,"CommonStockSharesConverted_0_Q1_shares":256351000.0,"CommonStockSharesOutstanding_0_Q1_shares":256351000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":324784000.0,"NetIncomeLossConverted_1_Q1_USD":268631000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":260175000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":255695000.0,"StockholdersEquityConverted_0_Q1_USD":4723313000.0,"EarningsPerShareBasic_1_Q1_USD":1.05,"EarningsPerShareDiluted_1_Q1_USD":1.03,"RevenuesConverted_1_Q1_USD":858435000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190501"}]